Detalhe da pesquisa
1.
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.
N Engl J Med
; 390(5): 397-408, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294972
2.
Translational success of fundamental virology: a VSV-vectored Ebola vaccine.
J Virol
; 98(3): e0162723, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305150
3.
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Clin Infect Dis
; 78(4): 870-879, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967326
4.
Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults.
J Infect Dis
; 220(7): 1127-1135, 2019 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31505665
5.
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates.
Cell Rep
; 42(4): 112402, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061918
6.
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials.
Vaccine
; 40(46): 6599-6606, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208978
7.
A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults.
Hum Vaccin Immunother
; 18(5): 2046960, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290152
8.
Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines.
Vaccines (Basel)
; 10(9)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146524
9.
Development of Pandemic Vaccines: ERVEBO Case Study.
Vaccines (Basel)
; 9(3)2021 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668698
10.
Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials.
Lancet Microbe
; 2(2): e70-e78, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544244
11.
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission.
Emerg Microbes Infect
; 10(1): 651-663, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719915
12.
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease.
Vaccines (Basel)
; 8(4)2020 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352786
13.
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens.
NPJ Vaccines
; 5(1): 51, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32566261
14.
Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial.
Am J Trop Med Hyg
; 103(2): 855-863, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32394880
15.
Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults.
Hum Vaccin Immunother
; 15(9): 2195-2204, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427741
16.
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment.
Vaccine X
; 1: 100009, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384731
17.
Unprecedented pace and partnerships: the story of and lessons learned from one Ebola vaccine program.
Expert Rev Vaccines
; 17(10): 913-923, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30269612
18.
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.
Vaccine
; 36(45): 6883-6891, 2018 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30244873
19.
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.
Vaccine
; 35(35 Pt A): 4465-4469, 2017 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28647166
20.
A normal life in science.
Hum Vaccin
; 6(7): 528-31, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20622512